Roche Diagnostics ramps up for double-digit growth in India

With India's in vitro diagnostic market expected to grow at a 13% rate over the next several years, Roche Diagnostics ($RHHBY) views business prospects there as an enormous growth opportunity, Lance Little, managing director for the company's Indian operations, told The Times of India. To boost business, Roche plans to provide training and engineering support to labs that choose to use the company's diagnostics products. Among the products Roche will focus on, according to the story: Screening tests to ensure safe blood transfusions and a high-risk HPV diagnostic test. Story

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.